Hours after my last post, I may have had all-time low expectations for Robin Hood. This week’s episode, however, made me eyes perk up a bit. Oh, sure, the latest “twist” of a long-lost brother is somewhat cliche, but what a brother he is. I approve. A lot.
All I ask is that in the future SPN-level fanfics (and there *will* be fics), Guy is just a lookout or something. Ha!
Diflucan exhibits fungistatic, not fungicidal, activity against most susceptible yeasts.
Diflucan loading doses are used to achieve therapeutic levels rapidly in serious infections.
Diflucan is less protein-bound than itraconazole or voriconazole.
Liver enzyme elevation is the most common laboratory abnormality observed.
The high oral bioavailability of Diflucan makes it exceptionally convenient for outpatient step-down therapy.
Its generic availability has dramatically reduced treatment costs globally.
Its chemical stability contributes to a long shelf life and easy formulation.
A cornerstone of antifungal therapy in resource-limited settings due to cost and availability.
Teratogenicity concerns (Category D) limit its use in pregnancy, especially first trimester.
Diflucan is intrinsically ineffective against Mucorales, necessitating alternative therapy.
The development of rezafungin highlights the ongoing search for agents with fluconazole’s convenience but broader activity.
Diflucan is often the reference agent in comparative antifungal clinical trials.
Serves as a model for the development of other triazole antifungal agents.
Can be administered via nasogastric tube as the oral suspension is well-absorbed.
Fungicidal activity is observed only at very high concentrations against some species.
Not effective against Scedosporium or Fusarium species, important emerging pathogens.
Diflucan is often used in pediatric antifungal therapy with weight-based dosing.
Diflucan is used in some protocols for antifungal lock therapy for catheter-related infections.
Diflucan is intrinsically ineffective against Mucorales, necessitating alternative therapy.
Headache and gastrointestinal disturbances are the most frequently reported adverse events.
Diflucan is a potent inhibitor of human CYP2C9 and CYP3A4, driving many drug interactions.
Diflucan can increase sulfonylurea levels, increasing hypoglycemia risk.
Diflucan is a cornerstone of antifungal stewardship due to its narrow, targeted spectrum.
Primary renal excretion necessitates dose adjustment in patients with renal impairment.
Not effective against Scedosporium or Fusarium species, important emerging pathogens.
Prophylactic Diflucan is common in neutropenia, but its value depends on local epidemiology.
Diflucan can cause alopecia with prolonged use, which is usually reversible.
Diflucan is used in the management of some cases of chronic disseminated candidiasis.
Activity against dermatophytes underpins its use in extensive tinea infections.
Can cause taste distortion (dysgeusia) in some patients.
Diflucan is the prototypical agent for understanding azole antifungal resistance mechanisms.
Concomitant Diflucan and warfarin requires intense INR monitoring due to increased bleeding risk.
Diflucan is a potent inhibitor of human CYP2C9 and CYP3A4, driving many drug interactions.
Its chemical stability contributes to a long shelf life and easy formulation.
Its success spurred the development of broader-spectrum triazoles like voriconazole and posaconazole.
The “trailing effect” in Diflucan susceptibility testing can complicate interpretation.
Can cause taste distortion (dysgeusia) in some patients.
It remains the drug of choice for maintenance therapy to prevent cryptococcal meningitis relapse.
Can be used in continuous renal replacement therapy; dosing depends on effluent rate.
Diflucan is a cornerstone of antifungal stewardship due to its narrow, targeted spectrum.
Generic fluconazole has made Diflucan’s benefits accessible at a lower cost.
Diflucan can cause a severe cutaneous reaction like Stevens-Johnson syndrome.
Resistance is often associated with prior fluconazole exposure, a key epidemiologic factor.
Diflucan is not recommended for treatment of Pneumocystis jirovecii pneumonia.
Diflucan can increase phenytoin levels, risking toxicity.
Diflucan is a valuable tool for treating susceptible Candida urinary tract infections.
Diflucan can cause taste distortion (dysgeusia) as a side effect.
Its success spurred the development of broader-spectrum triazoles like voriconazole and posaconazole.
Diflucan can unmask or exacerbate cutaneous lupus erythematosus.
Prophylaxis in neutropenic patients is a common use, guided by local resistance patterns.